Warts and Molluscum in Children

Advances in Dermatology

Volumn 20, Issue , 2004, Pages 23-73

  Silverberg, Nanette B ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 2 HYDROXYACID; ALPHA INTERFERON; AMINOLEVULINIC ACID; BLEOMYCIN; CANDIDA ANTIGEN; CANTHARIDIN; CIDOFOVIR; CIMETIDINE; CORTICOSTEROID; DIPHENCYPRONE; ESTER DERIVATIVE; ETRETIN; ETRETINATE; FLUOROURACIL; IMIQUIMOD; LEVAMISOLE; LIDOCAINE; LIQUID NITROGEN; PARACETAMOL; PHENOL; PODOPHYLLOTOXIN; POTASSIUM HYDROXIDE; POTASSIUM NITRATE; RETINOID DERIVATIVE; SALICYLIC ACID; SILVER NITRATE; SQUARIC ACID; TRICHLOROACETIC ACID; TSUKUBAENOLIDE; VIRUS ANTIGEN; ANTIVIRUS AGENT;

BACTERIAL INFECTION; BLISTER; BOWENOID PAPULOSIS; CARBON DIOXIDE LASER; CELLULAR IMMUNITY; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CRYOTHERAPY; CYTOPENIA; DEFENSE MECHANISM; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG POTENTIATION; EROSION; ERYTHEMA; ERYTHEMA MULTIFORME; FOCAL EPITHELIUM HYPERPLASIA; GARLIC; GYNECOMASTIA; HAND PALM; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INNATE IMMUNITY; KERATOACANTHOMA; LEUKOPENIA; LYMPHANGITIS; LYMPHEDEMA; MENTAL DISEASE; MOLLUSCUM CONTAGIOSUM; MORPHOLOGY; PAIN; PHOTODYNAMIC THERAPY; PRURITUS; RAYNAUD PHENOMENON; REVIEW; RISK FACTOR; SCAR FORMATION; SCLEREDEMA; SIDE EFFECT; SKIN ABRASION; SKIN NECROSIS; SKIN PENETRATION; SKIN PIGMENTATION; SKIN PROTECTION; SKIN ULCER; TINEA VERSICOLOR; VASCULAR DISEASE; VERRUCA PLANA JUVENILIS; VERRUCA VULGARIS; VERRUCOUS CARCINOMA; VIRUS ADSORPTION; VIRUS DETECTION; VIRUS GENE; VIRUS PARTICLE; WART VIRUS; CHILD; CHILD WELFARE; IMMUNOLOGY; IMMUNOTHERAPY;

ANTIVIRAL AGENTS; CHILD; CHILD WELFARE; CRYOTHERAPY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY; MOLLUSCUM CONTAGIOSUM; WARTS;

EID: 16544389260     PISSN: 08820880     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (208)

1. Cobb MW: Human papillomavirus infection. J Am Acad Dermatol 22:547-566, 1990.
2. Torrelo A: What's new in the treatment of viral warts in children. Pediatr Dermatol 19:191-199, 2002.
3. Schiller JT, Lowy DR: Human papillomavirus vaccines for cervical cancer prevention. In: Plotkin SA, Orenstein WA, editors. Vaccines. Ed. 4. Philadelphia: Saunders; 2004, p 1259-1265.
4. Egawa K: Do human papillomaviruses target epidermal stem cells? Dermatology 207:251-254, 2003.
5. Schachner L, Ling NS, Press S: A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol 1:157-164, 1983.
6. Wisuthsarewong W, Viravan S: Analysis of skin diseases in a referral pediatric dermatology clinic in Thailand. J Med Assoc Thai 83:999-1004, 2000.
7. Larsson PA, Liden S: Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm Venereol (Stockh) 60:415-423, 1980.
8. Wenk C, Itin PH: Epidemiology of pediatric dermatology and allergology in the region of Aargau, Switzerland. Pediatr Dermatol 6:482-487, 2003.
9. Kilkenny M, Merlin K, Young R, et al: The prevalence of common skin conditions in Australian school students: Common, plane and plantar viral warts. Br J Dermatol 138:840-845, 1998.
10. Allen WH, Dickinson VA: The problem of verrucae. The Medical Officer 6:317-322, 1968.
11. Messing AM, Epstein WL: Natural history of warts: A 2 year study. Arch Dermatol 87:306-310, 1963.
12. Verbov J: How to manage warts. Arch Dis Child 80:97-99, 1999.
13. Cupp MR, Malek RS, Goellner JR, et al: Detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 154:1024-1029, 1995.
14. Jablonska S, Majewski S, Obalek S, et al: Cutaneous Warts. Clin Dermatol 15:309-319, 1997.
15. Lee S, Lee W, Chung S, et al: Detection of human papillomavirus 60 in epidermal cysts of nonpalmoplantar location. Am J Dermatopathol 25:243-247, 2003.
16. Skerlev M, Grce M, Sirotkoviae-Skerlev M, et al: Human papillomavirus male genital infections: Clinical variations and the significance of DNA typing. Clin Dermatol 20:173-178, 2002.
17. Powell J, Strauss S, Gray J, et al: Genital carriage of human papillomavirus (HPV) DNA in prepubertal girls with and without vulvar disease. Pediatr Dermatol 3:191-194, 2003.
18. Kawana K, Yasugi T, Yoshikawa T, et al: Evidence for the presence of neutralizing antibodies against human papillomavirus in infants born to mothers with condyloma acuminata. Am J Perinatol 20:11-16, 2003.
19. Frega A, Stentella P, De Ioris A, et al: Young women, cervical intraepithelial neoplasia and human papillomavirus: Risk factors for persistence and recurrence. Cancer Lett 196:127-134, 2003.
20. Montgomery SM, Ehlin AGC, Sparen P, et al: Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer 87:989-993, 2002.
21. Kui LL, Xhi HZ, Ning LY: Condyloma acuminatum and human papilloma virus infection in the oral mucosa of children. Pediatr Dent 25:149-153, 2003.
22. Guill CK, Hwang LY, Iyengar V, et al: Asymptomatic labial papules in a teenager: Focal epithelial hyperplasia. Arch Dermatol 138:1509-1514, 2002.
23. Nartey NO, Newman MA, Nyako EA: Focal epithelial hyperplasia: Report of six cases from Ghana, West Africa. J Clin Pediatr Dent 27:63-66, 2000.
24. Godfrey JC, Vaughan MC, Williams JV: Successful treatment of bowenoid papulosis in a 9-year-old girl with vertically acquired human immunodeficiency virus. Pediatrics 112:e73-e76, 2003.
25. Majewski S, Jablonska S: Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36:659-685, 1997.
26. Weitzner JM, Fields KW, Robinson MJ: Pediatric bowenoid papulosis: Risks and management. Pediatr Dermatol 6:303-305, 1989.
27. Nordin P, Stenquist B, Hansson BG: Joint occurrence of human papillomavirus type 16 DNA in Bowen's disease on the finger and in dysplasia of the vulva and the uterine cervix. Br J Dermatol 131:740, 1994.
28. Masini C, Fuchs PG, Gabrielli F, et al: Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 139:890-894, 2003.
29. Malejczyk J, Majewski S, Jablonska S: Cellular immunity in cutaneous and genital HPV infections. Clin Dermatol 15:261-274, 1997.
30. Iwatsuki K, Tagami H, Takigawa M, et al: Plane warts under spontaneous regression. Arch Dermatol 122:655-659, 1986.
31. Isaacson C, Kessis TD, Hedrick L, et al: Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with virus type. Cancer Res 56:669-674, 1996.
32. Yamamoto T, Nishioka K: Association of granzyme-B-positive lymphocytes in regressing plane warts. Dermatology 207:412-414, 2003.
33. Ciconte A, Campbell J, Tabrizi S, et al: Warts are not merely blemishes on the skin: A study on the morbidity associated with having viral cutaneous warts. Australas J Dermatol 44:163-173, 2003.
34. Rudlinger R, Smith IW, Bunney MH, et al: Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 115:681-692, 1986.
35. Lindelof B, Granath F, Dal H, et al: Sun habits in kidney transplant recipients with skin cancer: A case-control study of possible causative factors. Acta Dermatol Venereol 83:189-193, 2003.
36. Tschachler E, Bergstresser PR, Stingl G: HIV-related skin diseases. Lancet 348:659-663, 1996.
37. Spira R, Mignard M, Doutre MS, et al: Prevalence of cutaneous disorders in a population of HIV-infected patients. Arch Dermatol 134:1208-1212, 1998.
38. Asadullah K, Renz H, Docke W-D, et al: Verrucosis of the hands and feet in a patient with common immune deficiency. J Am Acad Dermatol 36:850-852, 1997.
39. Gorlin RJ, Gelb B, Diaz GA, et al: WHIM syndrome: An autosomal dominant disorder: Clinical, hematological and molecular studies. Am J Med Genet 91:368-376, 2000.
40. Gulino AV: WHIM syndrome: A genetic disorder of leukocyte trafficking. Curr Opin Allergy Clin Immunol 3:443-450, 2003.
41. Partridge ME, Pariser RJ: Ocular and cutaneous squamous cell carcinoma in an African American man with epidermodysplasia verruciformis resulting in blindness and death. J Am Acad Dermatol 49:S262-S264, 2003.
42. de Oliviera WR, Rady PL, Grady J, et al: Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis. J Am Acad Dermatol 49:639-643, 2003.
43. Montgomery SM, Ehlin AGC, Sparen P, et al: Childhood indicators of susceptibility to subsequent cervical cancer. Br J Cancer 87:989-993, 2002.
44. Johnson LW: Communal showers and the risk of plantar warts. J Fam Pract 40:136-138, 1995.
45. Favre M, Majewski S, Noszczyk B, et al: Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 114:403-407, 2000.
46. Mahe E, Bodemer C, Descamps V, et al: High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Br J Dermatol 149:819-825, 2003.
47. Bandyopadhyay D: Perianal verrucous epidermal naevus mimicking perianal warts. Sex Transm Infect 79:424-429, 2003.
48. Coppo P, Salomone R: Pseudoverrucous papules: An aspect of incontinence in children. JEADV 16:409-410, 2002.
49. Silverberg NB, Laude TA: Jacquet's diaper dermatitis: A diagnosis of exclusion. Pediatr Dermatol 15:489, 1998.
50. Gupta S, Takhar PPS, Degenkolbe R, et al: The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. Virology 317:155-164, 2003.
51. Gibbs S, Harvey I, Sterling JC, et al: Local treatments for cutaneous warts (Cochrane Review). In: The Cochrane Review, Issue 4. Chichester, UK: John Wiley and Sons; 2003.
52. Bunney NH, Nolan MW, Williams DA: An assessment of methods of treating viral warts by comparative treatment trials based on a standard design. Br J Dermatol 94:667-679, 1976.
53. Focht DR, Spicer C, Fairchok MP: The efficacy of duct tape vs. cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med 156:971-974, 2002.
54. Buckley D: Cryosurgery treatment of plantar warts. Ir Med J 95:140-143, 2000.
55. Hancox JG, Graham GF, Yosipovitch G: Hemorrhagic bullae after cryosurgery in a patient with hemophilia A. Dermatol Surg 29:1084-1086, 2003.
56. Ichiki Y: Lidocaine tape for reducing pain in the cryotherapy of warts. Pediatr Dermatol 16:481-482, 1999.
57. Gupta AK, Koren G, Shear NH: A double-blind, randomized, placebo-controlled trial of eutectic lidocaine/prilocaine cream 5% (EMLA) for analgesia prior to cryotherapy of warts in children and adults. Pediatr Dermatol 15:129-133, 1998.
58. Wagner AM, Suresh S: Peripheral nerve blocks for warts: Taking the cry out of cryotherapy and laser. Pediatr Dermatol 15:238-241, 1998.
59. Findlay GH: Wart relapses at the edge of therapeutic cantharidin blisters. Arch Dermatol 80:589-590, 1959.
60. Robson KA, Cunningham NM, Kruzan KL: Pulsed-dye laser versus conventional therapy in the treatment of warts: A prospective randomized trial. J Am Acad Dermatol 43:275-280, 2000.
61. Stazzon AM, Borgs P, Witte CL, et al: Lymphangitis and refractory lymphedema after treatment with topical cantharidin. Arch Dermatol 134:104-106, 1998.
62. Stender IM, Lock-Andersen J, Wulf HC: Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolevuaenic acid: A pilot study. Clin Exp Dermatol 24:154-159, 1999.
63. Mizuki D, Kaneko T, Hanada K: Successful treatment of topical photodynamic therapy using 5-aminolevulinic acid for plane warts. Br J Dermatol 149:1077-1094, 2003.
64. Seurer F, Soekh E: Successful treatment of recalcitrant warts in pediatric patients with carbon dioxide laser. Eur J Pediatr Surg 13:219-223, 2003.
65. Seki T, Tsuji K, Hayato Y, et al: Garlic and onion oils inhibit proliferation and induce differentiation of HL-60 cells. Cancer Lett 160:29-35, 2000.
66. Weber ND, Andersen DO, North JA, et al: In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med 58:417-423, 1992.
67. Kim-Park SA, Ku DD: Garlic elicits a nitric oxide-dependent relaxation and inhibits pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol 27:780-786, 2000.
68. Rafaat M, Leung AK: Garlic burns. Pediatr Dermatol 17:475-476, 2000.
69. Silverberg NB: Garlic cloves for verrucae vulgaris. Pediatr Dermatol 19:183, 2002.
70. Grussendorf-Conen EI, Jacobs S: Efficacy of imiquimod 5% in the treatment of recalcitrant warts in children. Pediatr Dermatol 19:263-266, 2002.
71. Oster-Schmidt C: Imiquimod: A new possibility for treatment resistant verrucae. Arch Dermatol 137:666-667, 2001.
72. Micali G, Dell'Oglio F, Nasca MR: An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts. J Dermatol Treat 14:233-236, 2003.
73. Hengge UR, Goos M, Arndt R: Topical treatment of warts and mollusca with imiquimod. Ann Int Med 32:95, 2000.
74. Hengge UR, Esser S, Schiltewolter T, et al: Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 143:1026-1031, 2000.
75. Majewski S, Pniewki T, Malejczyk M, et al: Imiquimod is highly effective for extensive, hyperproliferative condyloma in children. Pediatr Dermatol 5:440-442, 2003.
76. Wenzel K, Saka B, Zimmerman R, et al: Malignant conversion of florid oral and labial papillomatosis during topical immunotherapy with imiquimod. Med Microbiol Immunol 192:16, 2003.
77. Buckley DA, du Vivier AW: Topical immunotherapy in dermatology. Int J Clin Pract 53:130-137, 1999.
78. Silverberg NB, Lim JK, Paller AS, et al: Squaric acid immunotherapy for warts in children. J Am Acad Dermatol 42:803-808, 2000.
79. Lee AN, Mallory SB: Contact immunotherapy with squaric acid dibutyl ester for the treatment of recalcitrant warts. J Am Acad Dermatol 41:595-599, 1999.
80. Micali G, Dall'Oglia F, Tedeschi A, et al: Treatment of cutaneous warts with squaric acid dibutylester: A decade of experience. Arch Dermatol 136:556-557, 2000.
81. Upitis JA, Krol A: The use of diphencyclopropenone in the treatment of recalcitrant warts. J Cutan Med Surg 6:214-217, 2002.
82. Mastrolonardo M, Lopalco PL, Diaferio A: Topical immunotherapy with contact sensitizers: A model to study the natural history of delayed hypersensitivity. Contact Derm 47:210-214, 2002.
83. Nasca MR, Micali G, Pulvirenti N, et al: Transient leucoderma appearing in an untreated area following contact immunotherapy for alopecia areata. Eur J Dermatol 8:125-126, 1998.
84. Orlow SJ, Paller AS: Cimetidine for multiple viral warts in children. J Am Acad Dermatol 28:794-796, 1993.
85. Gooptu C, Higgins CR, James MP: Treatment of viral warts with cimetidine: An open label study. Clin Exp Dermatol 25:183-185, 2000.
86. Franco I: Oral cimetidine for the management of genital and perigenital warts in children. J Urol 164:1074-1075, 2000.
87. Parsad D, Pandi R, Juneja A, et al: Cimetidine and levamisole vs. cimetidine alone for recalcitrant warts in children. Pediatr Dermatol 18:349-352, 2001.
88. Bohle E, Buttner H, Jocham D: Primary treatment of condyloma acuminata with viable bacillus Camille-Guerin. J Urol 165:834-836, 2001.
89. Phillips RC, Ruhl TS, Pfenninger JL, et al: Treatment of warts with Candida antigen injection. Arch Dermatol 136:1274-1275, 2000.
90. Signore RJ: Candida albicans intralesional injection immunotherapy for warts. Cutis 70:185-192, 2002.
91. Signore RJ: Candida immunotherapy of warts. Arch Dermatol 137:1250-1251, 2001.
92. Clifton M, Johnson SM, Roberson PK, et al: Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol 3:268-271, 2003.
93. Johnson SM, Roberson PK, Horn TD: Intralesional injection of mumps or Candida skin test antigens. Arch Dermatol 137:451-455, 2001.
94. Nimura M: Application of beta-interferon in virus-reduced papillomas. J Invest Dermatol 95:149S-151S, 1990.
95. Klutke JJ, Bergman A: Interferon as adjuvant treatment for genital condyloma acuminatum. Int J Gyn Obstet 49:171-174, 1995.
96. Koutsky LA, Ault KA, Wheeler CM, et al: Proof of principle study investigators: A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651, 2002.
97. Santin AD, Bellone S, Gokden M, et al: Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med 346:1752-1753, 2002.
98. Meineke V, Reichrath J, Reinhold U, et al: Verrucae vulgaris in children: Successful simulated X-ray treatment (a suggestion-based therapy). Dermatology 204:287-289, 2002.
99. Bunney MH, Nolan MW, Buxton PK, et al: The treatment of resistant warts with intralesional bleomycin: a controlled clinical trial. Br J Dermatol 110:197-207, 1984.
100. van der Velden EM, Ijsselmuiden OE, Drost BHIM, et al: Dermatography and bleomycin as a new treatment for verrucae vulgaris. Int J Dermatol 36:145-150, 1997.
101. Munn SE, Higgins E, Marshall M, et al: A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol 135:969-971, 1996.
102. Wu C, Langan S, Kilmurray M, et al: Efficacy of pulsed-dye laser for viral warts - an internal audit. Irish Med J 96:81-83, 2003.
103. Ross BS, Levine VJ, Nehal K, et al: Pulsed dye laser treatments of warts: An update. Dermatol Surg 25:377-380, 1999.
104. Tan OT, Hurwitz RM, Staffort TJ: Pulse dye laser treatment of recurrent verrucae: A preliminary report. Laser Surg Med 13:127-137, 1993.
105. Kauvar ANB, McDaniel DH, Geronemus RG: Pulse dye laser treatment of warts. Arch Fam Med 4:1035-1040, 1995.
106. Tuncel A, Gorgu M, Ayhan M, et al: Treatment of anogenital warts by pulsed dye laser. Dermatol Surg 28:350-352, 2002.
107. Munoz Perez MA, Rodriguez-Pichardo A, Camacho F, et al: Dermatological findings correlated with CD 4 lymphocyte counts in a prospective three year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol 139:33-39, 1998.
108. Lacey CJN, Goodall RL, Tennvall GR, et al: Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, podophyllin in the treatment of genital warts. Sex Transm Infect 79:270-275, 2003.
109. Shelley WB, Shelley ED: Scrotal dermatitis caused by 5- fluorouracil. J Am Acad Dermatol 19:929-931, 1988.
110. Gubinelli E, Posteraro P, Cocuroccia B, et al: Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. J Dermatol Treat 14:184-188, 2003.
111. Tay YK, Tan SH: Multiple hyperpigmented scaly macules and papules. Pediatr Dermatol 20:176-178, 2003.
112. Schmook T, Nindl I, Ulnich C, et al: Viral warts in organ transplant recipients: New aspects in therapy. Br J Dermatol 149:20-24, 2003.
113. Orth G, Favre M, Majewski S, et al: Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses. J Virology 75:4952-4953, 2003.
114. Johnson LW: Communal showers and the risk of plantar warts. J Fam Pract 40:136-138, 1995.
115. Bunney MH: Prevention of plantar warts by the use of protective footwear in swimming pools. Community Med 10:127-129, 1972.
116. Vaile L, Finlay F, Dharma S: Should verrucae be covered while swimming? Arch Dis Child 88:236-237, 2003.
117. Diven DG: An overview of poxviruses. J Am Acad Dermatol 44:1-16, 2001.
118. Epstein WL: Molluscum contagiosum. Semin Dermatol 11:184-189, 1992.
119. Sturt RJ, Muller HK, Francis GD: Molluscum contagiosum in villages of the West Septik district of New Guinea. Med J Aust 2:751-754, 1971.
120. Dangall BG, Wilson GR: Molluscum contagiosum in a red kangaroo. Australas J Dermatol 15:115-120, 1974.
121. Douglas JD, Tanner KN, Prine JR, et al: Molluscum contagiosum in chimpanzees. J Am Vet Med Assoc 151:901-904, 1967.
122. Tyring SK: Molluscum contagiosum: The importance of early diagnosis and treatment. Am J Obstet Gynecol 189:S12-S16, 2003.
123. Porter CD, Blake NW, Archard LC, et al: Molluscum contagiosum virus types in genital and non-genital lesions. Br J Dermatol 120:37-41, 1989.
124. Thompson CH: Immunoreactive proteins of molluscum contagiosum virus types 1,1v, and 2. J Infect Dis 178:1230-1231, 1998.
125. Porter CD, Archard LC: Characterization by restriction mapping of three subtypes of molluscum contagiosum virus. J Med Virol 38:1-6, 1992.
126. Agromayor M, Ortiz P, Lopez-Estebaranz JL, et al: Molecular epidemiology of molluscum contagiosum virus and analysis of the host-serum antibody response in Spanish HIV-negative patients. J Med Virol 66:151-158, 2002.
127. Xiang Y, Moss B: Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J Virol 75:9947-9954, 2001.
128. Luttichau HR, Lewis IC, Gerstoft J, et al: The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur J Immunol 31:1217-1220, 2001.
129. Chen N, Baudino T, MacDonald PN, et al: Selective inhibition of nuclear steroid receptor function by a protein from a human tumorigenic poxvirus. Virology 274:17-25, 2000.
130. Garvey TL, Bertin J, Siegel RM, et al: Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J Virol 76:79-84, 2002.
131. Smith KJ, Yeager J, Skelton H: Molluscum contagiosum: Its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol 38:664-672, 1999.
132. Senkevich TG, Bugert JJ, Sisler JR, et al: Genome sequence of a human tumorigenic poxvirus: Prediction of specific host response-evasion genes. Science 273:813-816, 1996.
133. Koning S, Bruijnzeels MA, Van Suijekom-Smit LW, et al: Molluscum contagiosum in Dutch general practice. Br J Gen Pract 44:417-419, 1994.
134. De Ore GA, Johnson HH, Binkley GW: An eczematous reaction associated with molluscum contagiosum. Arch Dermatol 74:344-348, 1956.
135. Silverberg NB, Sidbury R, Mancini AJ: Childhood molluscum contagiosum: Experience with cantharidin therapy in 300 patients. J Am Acad Dermatol 43:503-507, 2000.
136. Fornatora ML, Reich RF, Gray RG, Freedman PD: Intraoral molluscum contagiosum: A report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:318-320, 2001.
137. Jang KA, Kim SH, Choi JH, et al: Viral folliculitis on the face. Br J Dermatol 142:555-559, 2000.
138. Brandrup F, Asschenfeldt P: Molluscum contagiosum-induced comedo and secondary abscess formation. Pediatr Dermatol 33:263-265, 1989.
139. Rao VA, Baskaran RK, Krishnan MM: Unusual cases of molluscum contagiosum of the eye. Indian J Ophthalmol 33:263-265, 1985.
140. Ghura HS, Camp RD: Scarring molluscum contagiosum in patients with severe atopic dermatitis: Report of two cases. Br J Dermatol 144:1094-1095, 2001.
141. Ha SJ, Park YM, Cho SH, et al: Solitary giant molluscum contagiosum of the sole. Pediatr Dermatol 15:222-224, 1998.
142. Wiederkehr M, Schwartz RA: Giant proliferative molluscum contagiosum. Acta Derm Venereol (Ljubljana) 11:101-104, 2002.
143. Fivenson DP, Weltman RE, Gibson SH: Giant molluscum contagiosum presenting as basal cell carcinoma in an acquired immunodeficiency syndrome patient. J Am Acad Dermatol 19:912-914, 1988.
144. Charles NC, Friedberg DN: Epibulbar molluscum contagiosum in acquired immune deficiency syndrome. Case report and review of the literature. Ophthalmology 99:1123-1126, 1992.
145. Cribier B, Scrivener Y, Grosshans E: Molluscum contagiosum: Histologic patterns and associated lesions. A study of 578 cases. Am J Dermatopathol 23:99-103, 2001.
146. Lee HJ, Kwon JA, Kim JW: Erythema multiforme-like molluscum dermatitis. Acta Derm Venereol 82:217-218, 2002.
147. Furue M, Akasu R, Ohtake N, et al: Erythema annulare centrifugum induced by molluscum contagiosum. Br J Dermatol 129:646-647, 1993.
148. deDiego J, Berridi D, Saracibar N, et al: Cutaneous pseudolymphoma in association with molluscum contagiosum. Am J Dermatopathol 20:518-521, 1998.
149. Oren B, Wende SO: An outbreak of molluscum contagiosum in a kibbutz. Infection 19:159-161, 1991.
150. Vander Straten M, Tyring SK: Mucocutaneous manifestations of viral diseases in children. Clin Dermatol 20:67-73, 2002.
151. Becker TM, Blount JH, Douglas J, et al: Trends in molluscum contagiosum in the United States, 1966-1983. Sex Transm Dis 13:88-92, 1986.
152. Myskowski PL: Molluscum contagiosum. Arch Dermatol 133:1039-1041, 1997.
153. Weinberg JM, Mysliwiec A, Turiansky GW, et al: Viral folliculitis: Atypical presentations of herpes simplex, herpes zoster, and molluscum contagiosum. Arch Dermatol 133:983-986, 1997.
154. Castilla MT, Sanzo JM, Fuentes S: Molluscum contagiosum in children and its relationship to attendance at swimming-pools: An epidemiological study. Dermatology (Basel) 191:165, 1995.
155. Mobacken H, Nordin P: Molluscum contagiosum among cross-country runners. J Am Acad Dermatol 17:519-520, 1987.
156. Halstead ME, Bernhardt DT: Common infections in the young athlete. Pediatr Ann 31:42-48, 2002.
157. Bargman H, Schachner L, Hankin D: Is genital molluscum contagiosum a cutaneous manifestation of sexual abuse in children? J Am Acad Dermatol 14:847-849, 1986.
158. Hughes WT, Parham DM: Molluscum contagiosum in children with cancer or acquired immunodeficiency syndrome. Pediatr Infect Dis J 10:152-156, 1991.
159. Stefanaki C, Stratigos AJ, Stratigos JD: Skin manifestations of HIV-1 infection in children. Clin Dermatol 20:74-86, 2002.
160. Schwartz JJ, Myskowski PL: Molluscum contagiosum in patients with human immunodeficiency virus infection. J Am Acad Dermatol 27:583-588, 1992.
161. Koopman RJ, van Merrienboer FC, Vredenin SG, et al: Molluscum contagiosum: A marker for advanced HIV infection. Br J Dermatol 126:528-529, 1992.
162. Cotton DWK, Cooper C, Barrett DF, et al: Severe atypical molluscum contagiosum infection in an immunocompromised host. Br J Dermatol 116:871-876, 1987.
163. Euvard S, Kanitakis J, Cochat P, et al: Skin diseases in children with organ transplants. J Am Acad Dermatol 44:932-939, 2001.
164. Mayumi M, Yamaoka K, Tsutsui T, et al: Selective immunoglobulin M deficiency associated with disseminated molluscum contagiosum. Eur J Pediatr 145:99-103, 1986.
165. Piccinno R, Carrel CF, Minni S, et al: Preputial ectopic sebaceous glands mimicking molluscum contagiosum. Acta Derm Venereal 70:344-345, 1990.
166. Micali G, Innocenzi D, Nasca MR, et al: Infezioni anogenitali da human papillomavirus (HPV) ed oncogenesi virale: Recenti acquisizioni. Pragma s.r.l. ed, Milano, 2003.
167. Papa CM, Berger RS: Venereal herpes-like molluscum contagiosum: Treatment with tretinoin. Cutis 18:537-540, 1976.
168. Laughter D, Istvan JA, Tofte SJ, et al: The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. 43:649-655, 2000.
169. Azon-Masoliver A, Gonzalez-Clemente J, Pedrol E, et al: Herpetiform and mollusca contagiosa-like cutaneous cryptococcosis in a patient with AIDS. Br J Dermatol 121:665-667, 1989.
170. Cooper CR Jr, McGinnis MR: Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen. Arch Pathol Lab Med 121:798-804, 1997.
171. Steffen C, Markman J-A: Spontaneous disappearance of molluscum contagiosum. Arch Dermatol 116:923-924, 1980.
172. Ogino A, Ishida H: Spontaneous regression of generalized molluscum contagiosum turning black. Acta Derm Venereol (Stockh) 64:83-86, 1984.
173. Hwang Y, Wang B, Bushman FD: Molluscum contagiosum virus topoisomerase: Purification, activities, and response to inhibitors. J Virol 72:3401-3406, 1998.
174. Moss B, Shisler JL, Xiang Y, et al: Immune-defense molecules of Molluscum contagiosum virus, a human poxvirus. Trends Microbiol 8:473-477, 2000.
175. Shisler JL, Senkevich TG, Berry MJ, et al: Ultraviolet-induced cell death blocked by a selenoprotein from a dermatotropic poxvirus. Science 279:102-105, 1998.
176. Weller R, O'Callaghan CJ, MacSween RM, et al: Scarring in Molluscum contagiosum: Comparison of physical expression and phenol ablation. BMJ 11:319:1540, 1999.
177. Laughter D, Istvan JA, Tofte SJ, et al: The prevalence of atopic dermatitis in Oregon school children. J Am Acad Dermatol 43:649-655, 2000.
178. Moed L, Shwayder TA, Chang MW: Cantharidin revisited: A blistering defense of an ancient medicine. Arch Dermatol 137:1357-1360, 2001.
179. Langley JM, Soder CM, Shlievert PM, et al: Case report: Molluscum contagiosum: Toxic shock syndrome following cantharidin treatment. Can Fam Phys 49:887-889, 2003.
180. Kuflik EG: Cryosurgery updated. J Am Acad Dermatol 37:82-84, 1994.
181. Ohkuma M: Molluscum contagiosum treated with iodine solution and salicylic acid plaster. Int J Dermatol 29:443-445, 1990.
182. Thomas JR III, Doyle JA: The therapeutic uses of topical vitamin A acid. J Am Acad Dermatol 4:505-513, 1981.
183. Garrett SJ, Robinson JK, Roenigk HH Jr: Trichloroacetic acid peel of molluscum contagiosum in immunocompromised patients. J Dermatol Surg Oncol 18:855-858, 1992.
184. Nizeki K, Hashimoto K: Treatment of molluscum contagiosum with silver nitrate paste. Pediatr Dermatol 16:395-397, 1999.
185. Rosdahl I, Edmar B, Gisslen H, et al: Curettage of molluscum contagiosum in children: Analgesia by topical application of a lidocaine/prilocaine cream (EMLA). Acta Derm Venereol 18:149-153, 1988.
186. de Waard-van der Spek FB, Oranje AP, Lillieborg S, et al: Treatment of molluscum contagiosum using a lidocaine/prilocaine cream (EMLA) for analgesia. J Am Acad Dermatol 23:685-688, 1990.
187. Rincon E, Baker RL, Iglesias AJ, et al: CNS toxicity after topical application of EMLA cream on a toddler with molluscum contagiosum. Pediatr Emerg Care 16: 252-254, 2000.
188. Moiin A: Photodynamic therapy for molluscum contagiosum infection in HIV-coinfected patients: Review of 6 patients. J Drugs Dermatol 2:637-639, 2003.
189. Lim DS, Egan CA: Insights into a novel treatment for molluscum. Acta Paediatr 92:265-266, 2003.
190. Liota E, Smith KJ, Buckley R, et al: Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 4:76-82, 2000.
191. Syed TA, Goswami J, Ahmadour OA, et al: Treatment of molluscum contagiosum, in males with an analog of imiquimod 1% in cream. J Dermatol (Tokyo) 25:309-313, 1998.
192. Ormerod AD, White MI, Shah SA, et al: Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream. Br J Dermatol 141:1051-1053, 1999.
193. Cunningham BB, Paller AS, Garzon M: Inefficacy of oral cimetidine for nonatopic children with molluscum contagiosum. Pediatr Dermatol 15:71-72, 1998.
194. Yashar SS, Shamiri B: Oral cimetidine treatment of molluscum contagiosum. Pediatr Dermatol 16:493, 1999.
195. Dohil M, Prendiville J: Treatment of molluscum contagiosum with oral cimetidine: Clinical experience in 13 patients. Pediatr Dermatol 13:310-312, 1996.
196. Silverman RA, Lucky A: Ken and Katie Caterpillar: Helpful props for treatment of molluscum contagiosum. Pediatr Dermatol 3:279-280, 2003.
197. Hughes PS: Treatment of molluscum contagiosum with the 585-nm pulsed dye laser. Dermatol Surg 24:229-230, 1998.
198. Hurni MA, Bohlen L, Furrer H, et al: Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined anti-retroviral therapy with saquinavir, zidovudine and lamivudine. AIDS 11:1784-1785, 1997.
199. Calista D, Morri M, Stagno A, et al: Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor. Am J Clin Dermatol 3:59-62, 2002.
200. Toro JR, Wood LV, Patel NK, et al: Topical cidofovir: A novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol 136:983-985, 2000.
201. Calista D: Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. J Eur Acad Dermatol Venereol 14:484-488, 2000.
202. Davies EG, Thrasher A, Lacey K, et al: Topical cidofovir for severe molluscum contagiosum. Lancet 353:2042, 1999.
203. Zabawski EJ: A review of topical and intralesional cidofovir. Dermatol Online J 6:3, 2000.
204. Syed TA, Lundin S, Ahmad M: Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology (Basel) 189:65-68, 1994.
205. Rajendran ES: Molluscum contagiosum: A case series. Homeopathy 91:255-259, 2002.
206. Romiti R, Ribeiro AP, Grinblat BM, et al: Treatment of molluscum contagiosum with potassium hydroxide: A clinical approach in 35 children. Pediatr Dermatol 16:228-231, 1999.
207. Lubbe J, Pournaras CC, Saurat JH: Eczema herpeticum during treatment of atopic dermatitis with 0.1% tacrolimus ointment. Dermatology (Basel) 201:249-251, 2000.
208. Hellier FF: Profuse mollusca contagiosa of the face induced by corticosteroids.Br J Dermatol 85:398, 1971.